A Reproducible Method for Detection of this Blood Clot Preventative 

A rapid, sensitive, and Reproducible Method has been developed for analysis of Ticagrelor. The data below, (overlay of 5 chromatograms ) illustrates how the compound can be adequately Retained and detected using a simple Gradient in Reversed Phase HPLC.  The Method demonstrates good Peak Shape and run-to-run Precision with RSD values less than 0.3%.

A Phenyl ring in the Column Stationary Phase provides beneficial π-π Interaction with the Analyte making possible the use of a very simple, Mass Spec friendly Mobile Phase with Formic Acid as an additive.

5 Injections of Ticagrelor Overlay

Method Conditions
Column: Cogent Phenyl Hydride™, 4μm, 100Å
Catalog No.: 69020-10P-2
Dimensions: 2.1mm x 100mm
Mobile Phase:
A: DI Water with 0.1% Formic Acid (v/v)
B: Acetonitrile with 0.1% Formic Acid (v/v)

Time (minutes) %B
0 40
1 40
5 85
6 85
7 40
10 40

Injection vol.: 1μL
Flow rate: 0.2mL / minute
Detection: UV @ 254nm
Sample Preparation: 2.0mg / mL Ticagrelor standard solution in Methanol.

Notes: Ticagrelor is an oral prescription indicated for treatment of acute ischemic stroke, coronary artery disease and acute coronary syndrome.

image_pdfDownload this Page